» Articles » PMID: 28427761

Multidisciplinary Management of Head and Neck Cancer: First Expert Consensus Using Delphi Methodology from the Spanish Society for Head and Neck Cancer (part 1)

Overview
Journal Oral Oncol
Publisher Elsevier
Specialty Dentistry
Date 2017 Apr 22
PMID 28427761
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Head and neck cancer is one of the most frequent malignances worldwide. Despite the site-specific multimodality therapy, up to half of the patients will develop recurrence. Treatment selection based on a multidisciplinary tumor board represents the cornerstone of head and neck cancer, as it is essential for achieving the best results, not only in terms of outcome, but also in terms of organ-function preservation and quality of life. Evidence-based international and national clinical practice guidelines for head and neck cancer not always provide answers in terms of decision-making that specialists must deal with in their daily practice. This is the first Expert Consensus on the Multidisciplinary Approach for Head and Neck Squamous Cell Carcinoma (HNSCC) elaborated by the Spanish Society for Head and Neck Cancer and based on a Delphi methodology. It offers several specific recommendations based on the available evidence and the expertise of our specialists to facilitate decision-making of all health-care specialists involved.

Citing Articles

Clinical characteristics and outcomes of persistent bacteremia in patients with head and neck cancer in a tertiary care hospital.

Kitaya S, Kanamori H, Ishii R, Katsumi M, Ikeda R, Higashi K Front Med (Lausanne). 2024; 11:1406983.

PMID: 38983366 PMC: 11232632. DOI: 10.3389/fmed.2024.1406983.


Caffeic acid phenethyl ester: Unveiling its potential as a potent apoptosis inducer for combating hypopharyngeal squamous cell carcinoma.

Kim H, Ahn M, Shin J, Choi S, Yu H, Cho S Oncol Rep. 2023; 51(2).

PMID: 38099422 PMC: 10777462. DOI: 10.3892/or.2023.8680.


Changes in multidisciplinary team decisions in a high volume head and neck oncological center following those made in its preferred partner.

Hendrickx J, Mennega T, Uppelschoten J, Leemans C Front Oncol. 2023; 13:1205224.

PMID: 37727212 PMC: 10505803. DOI: 10.3389/fonc.2023.1205224.


Multidisciplinary tumor board for head and neck cancer from the perspective of medical oncologists-optimizing its effectiveness.

Yokota T, Mukaigawa T, Yasunaga Y, Ogawa H, Onoe T, Yurikusa T Front Oncol. 2023; 13:1257853.

PMID: 37711197 PMC: 10498916. DOI: 10.3389/fonc.2023.1257853.


Squamous Cell Carcinoma of the Oral Cavity, Oropharynx, and Larynx: A Scoping Review of Treatment Guidelines Worldwide.

Arboleda L, de Carvalho G, Santos-Silva A, Fernandes G, Vartanian J, Conway D Cancers (Basel). 2023; 15(17).

PMID: 37686681 PMC: 10486835. DOI: 10.3390/cancers15174405.